COSCIENS Biopharma's total assets for Q2 2026 were $18.82M, a decrease of -0.18% from the previous quarter. DE:ET80 total liabilities were $4.00M for the fiscal quarter, a 13.56% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.